Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14730
Articles
Company
Deals
We-Linking Raises Tens of Millions in Angel Round for Brain-Computer Interface
January 18, 2025
Company
Deals
Hybio Pharma and CR Medicine Collaborate on Market Expansion
January 18, 2025
Company
Drug
Junshi Biosciences Seeks UK MHRA Approval for PD-1 Inhibitor Tuoyi
January 18, 2025
Company
Drug
Chinagene Tech Initiates ZVS101e Gene Therapy Trial for Bietti’s Crystalline Dystrophy
January 18, 2025
Company
Drug
Ascletis Pharma’s ASC10 Shows Promising Phase I Results at CROI 2023
January 18, 2025
Company
Deals
Beijing Huashen Shengdian Secures Angel Funding for Pelvic Surgery Monitor R&D
January 18, 2025
Company
Drug
Zhaoke’s Generic Bimatoprost + Timolol Maleate Eye Drops Approved in China
January 18, 2025
Company
Drug
Sino Biopharmaceutical’s Limaprost Approved by NMPA for Lumbar Spinal Stenosis Treatment
January 18, 2025
Company
R&D
Biocytogen’s ‘Nano 100 Project’ Aims to Develop Over 100 Fully Human Nanobody Drugs
January 18, 2025
Company
Deals
Suzhou Porton Biologics Partners with Yinjia Biosciences for CGT Development
January 18, 2025
Company
Drug
Biosyngen’s BRG01 Gets FDA Nod for NPC Clinical Study
January 18, 2025
Policy / Regulatory
CDE Issues Guidelines for Real-World Drug Research and Evidence Framework
January 18, 2025
1
2
…
1,052
1,053
1,054
1,055
1,056
…
1,227
1,228
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?